Kazia Therapeutics Limited (KZIA) Ownership

$1.80

south_east
-$0 (0%)
Day's range
$1.76
Day's range
$1.86

Kazia Therapeutics Limited Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ADVISOR GROUP HOLDINGS, INC. 02/07/2025 500 $215   0.00% 0.02%
JPMORGAN CHASE & CO 02/12/2025 0 $0   -100.00% 0.00%
WELLS FARGO & COMPANY/MN 02/13/2025 0 $0   -100.00% 0.00%
COMMONWEALTH EQUITY SERVICES, LLC 02/10/2025 0 $0   -100.00% 0.00%
MAI CAPITAL MANAGEMENT 02/14/2025 0 $0   -100.00% 0.00%
RHUMBLINE ADVISERS 01/30/2025 0 $0   -100.00% 0.00%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 0 $0   -100.00% 0.00%
ADVISORNET FINANCIAL, INC 01/13/2025 0 $0   -100.00% 0.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 0 $0   -100.00% 0.00%
ALLWORTH FINANCIAL LP 01/30/2025 0 $0   -100.00% 0.00%
JANE STREET GROUP, LLC 02/14/2025 0 $0   -100.00% 0.00%
UBS GROUP AG 02/14/2025 0 $0   -100.00% 0.00%
TRAYNOR CAPITAL MANAGEMENT, INC. 01/17/2025 0 $0   -100.00% 0.00%
XTX TOPCO LTD 02/13/2025 0 $0   -100.00% 0.00%

Kazia Therapeutics Limited institutional Ownership - FAQ's

During the previous two years, 17 institutional investors and hedge funds held shares of Kazia Therapeutics Limited. The most heavily invested institutionals were:

ADVISOR GROUP HOLDINGS, INC.: 500

RHUMBLINE ADVISERS: 0

JANE STREET GROUP, LLC: 0

COMMONWEALTH EQUITY SERVICES, LLC: 0

GEODE CAPITAL MANAGEMENT, LLC: 0

XTX Topco Ltd: 0

0.02% of Kazia Therapeutics Limited stock is owned by institutional investors.

Institutional investors have bought a total of 325,362 shares in the last 24 months. This purchase volume represents approximately $585,652 in transactions.